Phase 3 Study to Assess the Efficacy and Safety of Batoclimab as Induction and Maintenance Therapy in Adult Participants With Generalized Myasthenia Gravis
Public ClinicalTrials.gov record NCT05403541. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Multi-center, Randomized, Quadruple-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Batoclimab as Induction and Maintenance Therapy in Adult Participants With Generalized Myasthenia Gravis (gMG)
Study identification
- NCT ID
- NCT05403541
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Immunovant Sciences GmbH
- Industry
- Enrollment
- 240 participants
Conditions and interventions
Conditions
Interventions
- Batoclimab 340 mg SC bi-weekly Drug
- Batoclimab 340 mg SC weekly Drug
- Batoclimab 680 mg SC weekly Drug
- Matching Placebo SC Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 26, 2022
- Primary completion
- Jan 9, 2025
- Completion
- Jan 31, 2027
- Last update posted
- Mar 24, 2026
2022 – 2027
United States locations
- U.S. sites
- 30
- U.S. states
- 17
- U.S. cities
- 30
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site Number -1022 | Phoenix | Arizona | 85028 | — |
| Site Number -1029 | Scottsdale | Arizona | 85251 | — |
| Site Number -1002 | Carlsbad | California | 92011 | — |
| Site Number -1009 | Irvine | California | 92697 | — |
| Site Number - 1012 | Olive View | California | 91342 | — |
| Site Number -1032 | San Francisco | California | 94143 | — |
| Site Number - 1027 | Aurora | Colorado | 80045 | — |
| Site Number - 1025 | New Haven | Connecticut | 06519 | — |
| Site Number -1007 | Clearwater | Florida | 33761 | — |
| Site Number -1010 | Maitland | Florida | 32751 | — |
| Site Number - 1020 | Miami | Florida | 33136 | — |
| Site Number - 1019 | Orlando | Florida | 32806 | — |
| Site Number - 1028 | Port Charlotte | Florida | 33952 | — |
| Site Number - 1015 | Tampa | Florida | 33612 | — |
| Site Number -1011 | Fairway | Kansas | 66205 | — |
| Site Number -1003 | Lexington | Kentucky | 40536 | — |
| Site Number -1013 | East Lansing | Michigan | 48824 | — |
| Site Number - 1024 | Minneapolis | Minnesota | 55414 | — |
| Site Number - 1021 | Buffalo | New York | 14203 | — |
| Site Number - 1018 | Chapel Hill | North Carolina | 27599 | — |
| Site Number - 1008 | Durham | North Carolina | 27710 | — |
| Site Number -1004 | Cleveland | Ohio | 44195 | — |
| Site Number -1006 | Portland | Oregon | 97239 | — |
| Site Number - 1023 | Philadelphia | Pennsylvania | 19104 | — |
| Site Number - 1026 | Memphis | Tennessee | 38120 | — |
| Site Number -1001 | Austin | Texas | 78759 | — |
| Site Number -1016 | Dallas | Texas | 75206 | — |
| Site Number - 1034 | Houston | Texas | 77030 | — |
| Site Number - 1014 | Round Rock | Texas | 78681 | — |
| Site Number -1005 | Charlottesville | Virginia | 22908 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 63 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05403541, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 24, 2026 · Synced May 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05403541 live on ClinicalTrials.gov.